• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊 1980 至 2005 年期间宫颈癌、子宫体癌和卵巢癌死亡率:趋势分析。

Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysis.

机构信息

Department of Hygiene, Medical School, Aristotle University of Thessaloniki, Hippokrateion Hospital, Thessaloniki, Greece.

出版信息

Int J Gynecol Cancer. 2010 May;20(4):482-7. doi: 10.1111/IGC.0b013e3181d80a8f.

DOI:10.1111/IGC.0b013e3181d80a8f
PMID:20686368
Abstract

INTRODUCTION

The aim of the present study was to analyze cervical, uterine corpus, and ovarian cancer mortality, between 1980 and 2005, in Greece.

METHODS

Mortality data and population age distribution were provided by the National Statistical Service of Greece. Time trends of mortality were calculated for each tumor type per 100,000 women in the whole female population of Greece, and 2 different age groups, that is, women aged 49 years and younger and those 50 years and older. Joinpoint regression was used for further analysis of mortality trends.

RESULTS

Overall, cervical and uterine corpus cancer mortality in the whole female population of Greece had a slightly decreasing trend between 1980 and 2005, whereas ovarian cancer mortality rates increased steadily throughout the period studied. Subgroup analyses according to age showed that cervical cancer mortality decreased very slightly only in women older than 50 years, whereas it remained steady in younger women. Uterine corpus cancer mortality decreased slightly in both age groups, but increased during the last years of the study period in the older age group. Ovarian cancer mortality increased in women older than 50 years, whereas it remained steady in the younger age group. Joinpoint regression analysis showed that only the increase after 1997 in the mortality trend for uterine corpus cancer in women 50 years and older was statistically significant (P = 0.0044).

CONCLUSIONS

Although our findings regarding cervical cancer mortality in Greece are encouraging, still more efforts are needed, particularly in preventing cervical cancer in younger women. The increasing trend of uterine corpus and ovarian cancer mortality in older women suggests that development of well-organized tertiary centers for the implementation of modern therapeutic modalities is urgently needed.

摘要

简介

本研究旨在分析 1980 年至 2005 年期间希腊的宫颈癌、子宫体癌和卵巢癌死亡率。

方法

希腊国家统计局提供了死亡率数据和人口年龄分布。按每 10 万希腊女性总人口和 2 个不同年龄组(49 岁及以下和 50 岁及以上)计算了每种肿瘤类型的死亡率。使用 Joinpoint 回归进一步分析死亡率趋势。

结果

总体而言,希腊女性总人口的宫颈癌和子宫体癌死亡率在 1980 年至 2005 年间呈略有下降趋势,而卵巢癌死亡率在整个研究期间呈稳步上升趋势。根据年龄的亚组分析显示,只有 50 岁以上的女性宫颈癌死亡率略有下降,而年轻女性的死亡率则保持稳定。子宫体癌死亡率在两个年龄组均略有下降,但在老年组的研究后期有所增加。卵巢癌死亡率在 50 岁以上的女性中增加,而在年轻年龄组中保持稳定。Joinpoint 回归分析显示,仅在 1997 年后 50 岁及以上女性子宫体癌死亡率呈上升趋势,具有统计学意义(P=0.0044)。

结论

尽管我们对希腊宫颈癌死亡率的发现令人鼓舞,但仍需要做出更多努力,特别是在预防年轻女性的宫颈癌方面。老年女性子宫体癌和卵巢癌死亡率的上升趋势表明,迫切需要建立组织良好的三级中心,以实施现代治疗模式。

相似文献

1
Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysis.希腊 1980 至 2005 年期间宫颈癌、子宫体癌和卵巢癌死亡率:趋势分析。
Int J Gynecol Cancer. 2010 May;20(4):482-7. doi: 10.1111/IGC.0b013e3181d80a8f.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
4
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
5
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
6
Optimal primary surgical treatment for advanced epithelial ovarian cancer.晚期上皮性卵巢癌的最佳初次手术治疗
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2.
7
Impact of definitive uterine artery occlusion on ovarian reserve markers in laparoscopic myomectomy: a randomized controlled trial with 2-year follow-up.根治性子宫动脉闭塞对腹腔镜子宫肌瘤剔除术中卵巢储备指标的影响:一项为期2年随访的随机对照试验
Hum Reprod. 2025 Jul 1;40(7):1305-1314. doi: 10.1093/humrep/deaf070.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Mortality of Three Major Gynecological Cancers in the European Region: An Age-Period-Cohort Analysis from 1992 to 2021 and Predictions in a 25‑Year Period.欧洲地区三大妇科癌症的死亡率:1992年至2021年的年龄-时期-队列分析及25年期间的预测
Ann Glob Health. 2025 Jun 10;91(1):30. doi: 10.5334/aogh.4688. eCollection 2025.
10
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.

引用本文的文献

1
Bax and Bak expression in cervical smears of women with low-and high-risk HPV types: A study of 120 cases.低风险和高风险人乳头瘤病毒类型女性宫颈涂片中巴克斯蛋白和巴库蛋白的表达:一项120例病例的研究
J Cytol. 2015 Oct-Dec;32(4):223-9. doi: 10.4103/0970-9371.171222.